PTPhillip I. Tarr

Phillip I. Tarr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phillip I. Tarr has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Srdjan Jelacic

    University of Washington, Department of Anesthesiology and Pain Medicine, 1959 NE Pacific St, Seattle, WA 98195-6540, USA

    4 shared publications
  • Rebecca L. Habeeb

    2 shared publications
  • Teresa R. Ward

    Children's Hospital and Regional Medical Center1 and University of Washington School of Medicine,2 Seattle, Washington 98105, and Pennsylvania State University, University Park, Pennsylvania 168023

    2 shared publications
  • Yoo-Lee Yea

    Children's Hospital and Regional Medical Center1 and University of Washington School of Medicine,2 Seattle, Washington 98105, and Pennsylvania State University, University Park, Pennsylvania 168023

    2 shared publications
  • Ann E. Stapleton

    Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA

    1 shared publication
  • Carla R. Clausen

    Departments of Laboratory Medicine 1 and

    1 shared publication

Latest Publications

  • Open Access

    Escherichia coliO157:H7 Infections: Discordance between Filterable Fecal Shiga Toxin and Disease Outcome

    by Nancy A. Cornick, Srdjan Jelacic, Marcia A. Ciol, Phillip I. Tarr

    Shiga toxin (Stx)–producing Escherichia coli O157:H7 are the most common cause of hemolytic uremic syndrome (HUS). We detected free fecal Stx in 48%,


  • Open Access

    Analysis of Urinary Escherichia coli Isolates for Ability To Produce Shiga Toxin

    by James R. Johnson, Catherine Jerome, Daniel R. Boster, Ann E. Stapleton, Phillip I. Tarr

    The frequency of Shiga toxin (Stx)-producing Escherichia coli (STEC) in the urinary tract, which can precipitate the hemolytic-uremic syndrome, is unknown. We tested 597 urinary E. coli isolates by Stx immunoassay and found no STEC. The routine screening of urinary E. coli for the ability to produce Stx is not warranted.


  • Escherichia coli O157:H7

    by Phillip I. Tarr, Marguerite A. Neill


  • Acquisition of the rfb-gnd Cluster in Evolution of Escherichia coli O55 and O157

    by Phillip I. Tarr, Laura M. Schoening, Yoo-Lee Yea, Teresa R. Ward, Srdjan Jelacic, Thomas S. Whittam

    The rfb region specifies the structure of lipopolysaccharide side chains that comprise the diverse gram-negative bacterial somatic (O) antigens. The rfb locus is adjacent to gnd , which is a polymorphic gene encoding 6-phosphogluconate dehydrogenase. To determine if rfb and gnd cotransfer, we sequenced gnd in five O55 and 13 O157 strains of Escherichia coli. E. coli O157:H7 has a gnd allele (allele A ) that is only 82% identical to the gnd allele (allele D ) of closely related E. coli O55:H7. In contrast, gnd alleles of E. coli O55 in distant lineages are >99.9% identical to gnd allele D . Though gnd alleles B and C in E. coli O157 that are distantly related to E. coli O157:H7 are more similar to allele A than to allele D , there are nucleotide differences at 4 to 6% of their sites. Alleles B and C can be found in E. coli O157 in different lineages, but we have found allele A only in E. coli O157 belonging to the DEC5 lineage. DNA 3′ to the O55 gnd allele in diverse E. coli lineages has sequences homologous to tnpA of the Salmonella enterica serovar Typhimurium IS 200 element, E. coli Rhs elements (including an H-rpt gene), and portions of the O111 and O157 rfb regions. We conclude that rfb and gnd cotransferred into E. coli O55 and O157 in widely separated lineages and that recombination was responsible for recent antigenic shifts in the emergence of pathogenic E. coli O55 and O157.


  • Top Cited Papers
    Open Access

    The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment ofEscherichia coliO157:H7 Infections

    by Craig S. Wong, Srdjan Jelacic, Rebecca L. Habeeb, Sandra L. Watkins, Phillip I. Tarr

    Children with gastrointestinal infections caused by Escherichia coli O157:H7 are at risk for the hemolytic–uremic syndrome. Whether antibiotics alter this risk is unknown. We conducted a prospective cohort study of 71 children younger than 10 years of age who had diarrhea caused by E. coli O157:H7 to assess whether antibiotic treatment in these children affects the risk of the hemolytic–uremic syndrome and to assess the influence of confounding factors on this outcome. Estimates of relative risks were adjusted for possible confounding effects with the use of logistic-regression analysis. Among the 71 children, 9 (13 percent) received antibiotics and the hemolytic–uremic syndrome developed in 10 (14 percent). Five of these 10 children had received antibiotics. Factors significantly associated with the hemolytic–uremic syndrome were a higher initial white-cell count (relative risk, 1.3; 95 percent confidence interval, 1.1 to 1.5), evaluation with stool culture soon after the onset of illness (relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.8), and treatment with antibiotics (relative risk, 14.3; 95 percent confidence interval, 2.9 to 70.7). The clinical and laboratory characteristics of the 9 children who received antibiotics and the 62 who did not receive antibiotics were similar. In a multivariate analysis that was adjusted for the initial white-cell count and the day of illness on which stool was obtained for culture, antibiotic administration remained a risk factor for the development of the hemolytic–uremic syndrome (relative risk, 17.3; 95 percent confidence interval, 2.2 to 137). Antibiotic treatment of children with E. coli O157:H7 infection increases the risk of the hemolytic–uremic syndrome.


  • Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure

    by Phillip I. Tarr, Sima S. Bilge, James C. Vary, Srdjan Jelacic, Rebecca L. Habeeb, Teresa R. Ward, Michael R. Baylor, Thomas E. Besser

    The mechanisms used by Shiga toxin (Stx)-producing Escherichia coli to adhere to epithelial cells are incompletely understood. Two cosmids from an E. coli O157:H7 DNA library contain an adherence-conferring chromosomal gene encoding a protein similar to iron-regulated gene A (IrgA) of Vibrio cholerae (M. B. Goldberg, S. A. Boyko, J. R. Butterton, J. A. Stoebner, S. M. Payne, and S. B. Calderwood, Mol. Microbiol. 6:2407–2418, 1992). We have termed the product of this gene the IrgA homologue adhesin (Iha), which is encoded by iha . Iha is 67 kDa in E. coli O157:H7 and 78 kDa in laboratory E. coli and is structurally unlike other known adhesins. DNA adjacent to iha contains tellurite resistance loci and is conserved in structure in distantly related pathogenic E. coli , but it is absent from nontoxigenic E. coli O55:H7, sorbitol-fermenting Stx-producing E. coli O157:H−, and laboratory E. coli . We have termed this region the tellurite resistance- and adherence-conferring island. We conclude that Iha is a novel bacterial adherence-conferring protein and is contained within an E. coli chromosomal island of conserved structure. Pathogenic E. coli O157:H7 has only recently acquired this island.


  • Comparison of Escherichia coli O157:H7 Antigen Detection in Stool and Broth Cultures to That in Sorbitol-MacConkey Agar Stool Cultures

    by Jennifer R. Stapp, Srdjan Jelacic, Yoo-Lee Yea, Eileen J. Klein, Marc Fischer, Carla R. Clausen, Xuan Qin, David L. Swerdlow, Phillip I. Tarr

    We evaluated the Meridian IC-STAT direct fecal and broth culture antigen detection methods with samples from children infected withEscherichia coli O157:H7 and correlated the antigen detection results with the culture results. Stools of 16 children who had recently had stool cultures positive for this pathogen (population A) and 102 children with diarrhea of unknown cause (population B) were tested with the IC-STAT device (direct testing). Fecal broth cultures were also tested with this device (broth testing). The results were correlated to a standard of the combined yield from direct culture of stools on sorbitol-MacConkey (SMAC) agar and culture of broth on SMAC agar. Eleven (69%) of the population A stool specimens yieldedE. coli O157:H7 when plated directly on SMAC agar. Two more specimens yielded this pathogen when the broth culture was similarly plated. Of these 13 stool specimens, 8 and 13 were positive by direct and broth testing (respective sensitivities, 62 and 100%). Compared to the sensitivity of a simultaneously performed SMAC agar culture, the sensitivity of direct testing was 73%. Three (3%) of the population B stool specimens contained E. coli O157:H7 on SMAC agar culture; one and three of these stool specimens were positive by direct and broth testing, respectively. The direct and broth IC-STAT tests were 100% specific with samples from children from population B. Direct IC-STAT testing of stools is rapid, easily performed, and specific but is insufficiently sensitive to exclude the possibility of infection with E. coli O157:H7. Performing the IC-STAT test with a broth culture increases its sensitivity. However, attempts to recover E. coli O157:H7 by culture should not be abandoned but, rather, should be increased when the IC-STAT test result is positive.


  • Escherichia coli O157:H7 in Retail Ground Beef in Seattle: Results of a One-Year Prospective Study

    by Phillip I. Tarr, Nhiem Thanh Tran, Richard A. Wilson

    Escherichia coli O157:H7 was sought systematically in 1,400 samples of retail ground beef in Seattle in a 1-year prospective study. Sorbitol-nonfermenting, lactose-fermenting, indole-positive colon...